Spinogenix is classified as operating in the N/A industry, NAICS Code .
Investor Activity
Spinogenix has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
August 10, 2023
3
100%
$5 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Spinogenix is developing and marketing.
Spinogenix doesn't have any recent trademark applications, indicating Spinogenix is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
TAGS Pharmaceutical preparations for the treatment of neurological and psychiatric diseases
03/22/2021
See all trademarks and details in the Full Report.
Nearby Competitors
These companies are similar in business line and location to Spinogenix.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Spinogenix and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.